Success story featuring BellaSeno – a preclinical stage medical device startup aiming to introduce a new generation of absorbable implants for breast reconstruction.
The technological success of the Senella® platform depends upon efficient vascularisation of the porous space within the implant volume such that the infiltrating tissue is adequately nourished.
Due to this, it is very important that the pore architecture of the implant is designed to maximise fluid flow (and maximize fluid contact with the implant surfaces).
View Story
